Research Article

The Prevalence and Replication Capacity of a Tibetan Dominant HBV Strain, C/D Recombinant

Table 1

Distribution of HBV genotypes in enrolled Han patients and Tibetan patients.

ItemsStatistical description percentage (amount)/median (interquartile range)Statistical value value
Han patients ()Tibetan patients ()

GenotypeB 65.92% ()
C 30.57% ()
B/C 2.55% ()
C/D 0.96% ()
B 17.65% ()
C 5.88% ()
D 41.18% ()
C/D 35.29% ()
Fisher<0.001
GenderMale 84.08% ()
Female 15.92% ()
Male 82.35% ()
Female 17.65% ()
1
Age33.5 (15)38 (22.5)0.308
AlcoholAlcohol-abuse 18.47% ()
Alcohol-free 81.53% ()
Alcohol-abuse 35.29% ()
Alcohol-free 64.71% ()
0.1629
Family historyPositive 39.17% ()
Negative 60.83% ()
Positive 58.82% ()
Negative 41.18% ()
0.1752
ALT (IU/L)40 (41)38 (34.5)0.388
TB (umol/L)12.50 (9.44)12.82 (6.76)0.596
ALB (g/L)50.70 (23.60)47.50 (8.20)0.104
ALP (IU/L)91.50 (42)93 (34)0.831
GGT (IU/L)49 (50)45 (41)0.629
AFP (ng/mL)3.46 (4.25)3.06 (5.02)0.705
HBeAgPositive 66.56% ()
Negative 33.44% ()
Positive 76.47% ()
Negative 23.53% ()
0.5606
log10 HBVDNA (IU/mL)7.27 (3.21)6.13 (1.60)<0.001
BCP mutationA1762T/G1764A 16.56% ()
G1896A 16.56% ()
A1762T/G1764A/G1896A 2.55% ()
Others 3.50% ()
Not detected 60.83% ()
A1762T/G1764A 41.18% ()
G1896A 5.88% ()
A1762T/G1764A/G1896A 5.88% ()
Not detected 41.18% ()
Fisher0.02899
Fibroscan (Kpa)8.00 (6.20)10.45 (5.18)0.012